Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Intervalo de año de publicación
1.
J Am Heart Assoc ; 13(3): e032852, 2024 Feb 06.
Artículo en Inglés | MEDLINE | ID: mdl-38293925

RESUMEN

BACKGROUND: Simple, noninvasive, and repeatable screening methods are essential for assessing swallowing disorders. We focused on patients with acute stroke and aimed to assess the characteristics of swallowing screening tests, including the modified Mann Assessment of Swallowing Ability score, tongue pressure, and repetitive saliva swallowing test (RSST), compared with detailed videofluoroscopic swallowing study (VFSS) findings to contribute as a helpful resource for their comprehensive and complementary use. METHODS AND RESULTS: We enrolled first-ever patients with acute stroke conducting simultaneous assessments, including VFSS, modified Mann Assessment of Swallowing Ability score, tongue pressure measurement, and RSST. VFSS assessed aspiration, laryngeal penetration, oral cavity residue, vallecular residue, pharyngeal residue, and swallowing reflex delay. Screening tests were compared with VFSS findings, and multiple logistic analysis determined variable importance. Cutoff values for each abnormal VFSS finding were assessed using receiver operating characteristic analyses. We evaluated 346 patients (70.5±12.6 years of age, 143 women). The modified Mann Assessment of Swallowing Ability score was significantly associated with all findings except aspiration. Tongue pressure was significantly associated with oral cavity and pharyngeal residue. The RSST was significantly associated with all findings except oral cavity residue. Receiver operating characteristic analyses revealed that the minimum cutoff value for all VFSS abnormal findings was RSST ≤2. CONCLUSIONS: The modified Mann Assessment of Swallowing Ability is useful for broadly detecting swallowing disorders but may miss mild issues and aspiration. The RSST, with a score of ≤2, is valuable for indicating abnormal VFSS findings. Tongue pressure, especially in oral and pharyngeal residues, is useful. Combining these tests might enhance accuracy of the swallowing evaluation.


Asunto(s)
Trastornos de Deglución , Accidente Cerebrovascular , Anciano de 80 o más Años , Femenino , Humanos , Deglución , Trastornos de Deglución/diagnóstico , Trastornos de Deglución/etiología , Presión , Saliva , Accidente Cerebrovascular/complicaciones , Accidente Cerebrovascular/diagnóstico , Lengua/diagnóstico por imagen , Estudios Prospectivos
2.
Ann Hematol ; 103(3): 935-946, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38157001

RESUMEN

Epstein-Barr virus (EBV) reactivation can occur following allogenic hematopoietic stem cell transplantation (allo-HSCT). However, the clinical characteristics and outcomes of EBV-viral load are not well known. Thus, we retrospectively analyzed the clinical features and prognostic impact of the EBV viral load in 121 allo-HSCT recipients from our hospital. EBV DNA quantification was performed in whole blood after transplantation. Patients were grouped based on whether EBV DNA quantification reached > 1000 copies/mL during follow-up (N = 50) or not (N = 71). Patients with EBV > 1000 EBV copies/mL were relatively more common in the groups with graft versus host disease (GVHD) prophylaxis including ATG, haploidentical donor type, peripheral blood as a donor source, and acute GVHD II-IV. The 20-month OS and DFS were not significantly different between patients with < 1000 EBV copies/mL and patients with > 1000 EBV copies/mL (20-month OS, 56.0% vs. 60.6%; p = 0.503, 20-month DFS, 50.0% vs. 57.7%; p = 0.179). Immunosuppressant (ISS) dose reduction was achieved after the maximum increase in EBV in 41/50 (82%) patients. Additionally, 30/50 (60%) patients achieved a 50% dose reduction or no restarting of ISS within 3 months of the maximum EBV increase. Among cases wherein EBV DNA quantification reached > 1000 copies/mL, those that achieved rapid dose reduction of ISS tended to have longer overall survival ("not reached" vs 5.4 months, p < 0.001) and disease-free survival (88.4 months vs 5.3 months, p < 0.001) than those in patients who did not. Our data highlight the importance of rapid ISS reduction in post-transplant EBV reactivation.


Asunto(s)
Infecciones por Virus de Epstein-Barr , Enfermedad Injerto contra Huésped , Trasplante de Células Madre Hematopoyéticas , Trastornos Linfoproliferativos , Humanos , Herpesvirus Humano 4/fisiología , Infecciones por Virus de Epstein-Barr/tratamiento farmacológico , Estudios Retrospectivos , Carga Viral , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Inmunosupresores/uso terapéutico , Enfermedad Injerto contra Huésped/etiología , Enfermedad Injerto contra Huésped/prevención & control , Enfermedad Injerto contra Huésped/tratamiento farmacológico , ADN Viral , Trastornos Linfoproliferativos/etiología
3.
In. U.S. National Center for Earthquake Engineering Research (NCEER). Proceedings from the first U.S. Japan Workshop on Earthquake Protective Systems for Bridges. Buffalo, N.Y., U.S. National Center for Earthquake Engineering Research (NCEER), Feb. 1992. p.501-15, ilus, Tab.
Monografía en En | Desastres | ID: des-6349

RESUMEN

Experimental Menshin designs were carried out to determine whether they could be applied to seismic retrofitting of existing highway bridge substructures. Lead rubber bearings (LRB) were used as Menshin devices in these experimental designs to reduce the seismic loads acting on the substructures through their high damping rates and through dispersion of the seismic lateral loads by modifying the existing structural system into a multi-point elastic support system. And their effectiveness in seismically retrofitting the substructure was confirmed.(AU)


Asunto(s)
Ingeniería , Medidas de Seguridad , Gestión de Riesgos , 34661 , Proyectos de Investigación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA